We are live on ! Find out more
Scientech Research

Scientech Research Portfolio holdings

AUM $123M Turnover 94.02%
1-Year Est. Return 198.31%
This Fund
S&P 500
This Quarter Est. Return
+110.75%
1 Year Est. Return
+198.31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$3.5M
Cap. Flow
-$13M
Cap. Flow %
-10.55%
Top 10 Hldgs %
16.74%
Holding
635
New
186
Increased
16
Reduced
22
Closed
411
Avg Time Held
0.1 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Sector Composition

Rank Sector Weight
1 Technology 38.25%
2 Healthcare 18.64%
3 Miscellaneous 15.68%
4 Industrials 11.04%
5 Financials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FULC icon
176
Fulcrum Therapeutics
FULC
$288M
$105K 0.08%
+28,584
New +$174K
2026 Q2
0 quarters
CONL icon
177
GraniteShares 2x Long COIN Daily ETF
CONL
$312M
$101K 0.08%
23,638
-128,887
-85% -$916K
2025 Q3
3 quarters
CCCC icon
178
C4 Therapeutics
CCCC
$362M
$99.3K 0.08%
+21,260
New +$72.7K
2026 Q2
0 quarters
PTIR icon
179
GraniteShares 2x Long PLTR Daily ETF
PTIR
$230M
$96.6K 0.08%
+10,295
New +$141K
2026 Q2
0 quarters
HELP icon
180
Helus Pharma Inc. Common Stock
HELP
$648M
$93.1K 0.08%
+14,081
New +$70.4K
2026 Q2
0 quarters
LFVN icon
181
LifeVantage
LFVN
$63M
$92.7K 0.08%
+14,858
New +$90K
2026 Q2
0 quarters
ELDN icon
182
Eledon Pharmaceuticals
ELDN
$179M
$90K 0.07%
+22,844
New +$83.1K
2026 Q2
0 quarters
VERU icon
183
Veru
VERU
$35.6M
$88.9K 0.07%
+28,391
New +$72.3K
2026 Q2
0 quarters
RLMD icon
184
Relmada Therapeutics
RLMD
$449M
$81.8K 0.07%
11,826
-2,783
-19% -$19.4K
2026 Q1
1 quarter
ENGN icon
185
enGene Therapeutics
ENGN
$162M
$70.4K 0.06%
+40,710
New +$166K
2026 Q2
0 quarters
OPTU icon
186
Optimum Communications Inc
OPTU
$200M
$69.1K 0.06%
+47,659
New +$59.2K
2026 Q2
0 quarters
WKSP icon
187
Worksport
WKSP
$6.89M
$69K 0.06%
+63,321
New +$57.5K
2026 Q2
0 quarters
SABS icon
188
SAB Biotherapeutics
SABS
$267M
$68K 0.06%
17,446
+6,630
+61% +$24.7K
2026 Q1
1 quarter
ZNTL icon
189
Zentalis Pharmaceuticals
ZNTL
$167M
$66K 0.05%
+13,613
New +$54.3K
2026 Q2
0 quarters
STAK icon
190
STAK Inc
STAK
$29.6M
$62.9K 0.05%
+16,508
New +$38.8K
2026 Q2
0 quarters
INVZ icon
191
Innoviz Technologies
INVZ
$51.8M
$62.7K 0.05%
82,375
+60,323
+274% +$41.3K
2026 Q1
1 quarter
IVF icon
192
INVO Fertility Inc
IVF
$3.1M
$61.4K 0.05%
+8,085
New +$58.2K
2026 Q2
0 quarters
PUSA icon
193
Powerus Corporation Common Stock
PUSA
$222M
$59.1K 0.05%
+14,804
New +$62.1K
2026 Q2
0 quarters
NNOX icon
194
Nano X Imaging
NNOX
$25.4M
$58K 0.05%
+50,038
New +$94.2K
2026 Q2
0 quarters
KXIN icon
195
Kaixin Holdings
KXIN
$127M
$56.9K 0.05%
+14,178
New +$78K
2026 Q2
0 quarters
WHWK icon
196
Whitehawk Therapeutics
WHWK
$181M
$49.6K 0.04%
+10,838
New +$45.1K
2026 Q2
0 quarters
KPRX icon
197
Kiora Pharmaceuticals
KPRX
$5.44M
$49.3K 0.04%
+18,746
New +$47.1K
2026 Q2
0 quarters
IVVD icon
198
Invivyd
IVVD
$172M
$46.1K 0.04%
+52,893
New +$66.3K
2026 Q2
0 quarters
SNAP icon
199
Snap
SNAP
$9.08B
$45.9K 0.04%
10,340
-22,092
-68% -$121K
2026 Q1
1 quarter
ARQ icon
200
Arq
ARQ
$141M
$44.7K 0.04%
17,527
-17,101
-49% -$42.4K
2026 Q1
1 quarter

Similar funds

Scientech Research's Q2 2026 Portfolio in Review

As of Q2 2026, Scientech Research held 635 positions worth $123M, up 2.9% from $120M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Scientech Research withdrew a net $13M in Q2 2026, closing 411 positions and reducing 22 holdings. Its most notable exit was Applied Digital, an estimated $1.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 20% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Scientech Research opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $1M.

  • Scientech Research's largest Q2 2026 buy was T-Rex 2X Long MSTR Daily Target ETF: 61,800 shares worth $1M.
  • Scientech Research added most to Tempus AI in Q2 2026, an estimated $1.43M increase.
  • Scientech Research's biggest Q2 2026 reduction was Unusual Machines, cutting an estimated $992K.
  • Scientech Research fully exited Applied Digital in Q2 2026, selling an estimated $1.63M.
  • Scientech Research's ten largest holdings make up 17% of its $123M portfolio in Q2 2026.
  • Scientech Research opened 186 new positions and closed 411 in Q2 2026.
  • Scientech Research's portfolio value rose 2.9% quarter-over-quarter to $123M.

Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.